Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin
Publication
, Journal Article
Weinstock, RS; Goldberg, RB; Guyton, JR; Mazzone, T; Polis, A; Tomassini, JE; Desrosiers, E; Tershakovec, AM
Published in: CIRCULATION
October 31, 2006
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2006
Volume
114
Issue
18
Start / End Page
796 / 797
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Weinstock, R. S., Goldberg, R. B., Guyton, J. R., Mazzone, T., Polis, A., Tomassini, J. E., … Tershakovec, A. M. (2006). Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin. CIRCULATION, 114(18), 796–797.
Weinstock, Ruth S., Ronald B. Goldberg, John R. Guyton, Theodore Mazzone, Adam Polis, Joanne E. Tomassini, Elizabeth Desrosiers, and Andrew M. Tershakovec. “Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin.” CIRCULATION 114, no. 18 (October 31, 2006): 796–97.
Weinstock RS, Goldberg RB, Guyton JR, Mazzone T, Polis A, Tomassini JE, et al. Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin. CIRCULATION. 2006 Oct 31;114(18):796–7.
Weinstock, Ruth S., et al. “Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin.” CIRCULATION, vol. 114, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2006, pp. 796–97.
Weinstock RS, Goldberg RB, Guyton JR, Mazzone T, Polis A, Tomassini JE, Desrosiers E, Tershakovec AM. Enhanced attainment of optional recommended levels of LDL-C, apolipoprotein B, non-HDL and hsCRP in type 2 diabetes patients treated with ezetimibe/simvastatin compared to atorvastatin. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006 Oct 31;114(18):796–797.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2006
Volume
114
Issue
18
Start / End Page
796 / 797
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology